Souffle Therapeutics
Series ASouffle Therapeutics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($200m), dated Oct 07, 2025. Institutional investors on record include Bessemer Venture Partners.
United States · EST 2021
What is Souffle Therapeutics?
Souffle Therapeutics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($200m), dated Oct 07, 2025. Institutional investors on record include Bessemer Venture Partners. Developer of nucleic acid medicines targeting specific cell surface receptors. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed Souffle Therapeutics?
Who invested in Souffle Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Bessemer Venture Partners | Series A | $200m | Oct 07, 2025 |
What do founders ask about Souffle Therapeutics?
What is Souffle Therapeutics?
Souffle Therapeutics is a privately held company based in United States, founded in 2021. The latest disclosed round is Series A ($200m), dated Oct 07, 2025. Institutional investors on record include Bessemer Venture Partners. Developer of nucleic acid medicines targeting specific cell surface receptors. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was Souffle Therapeutics's last funding round?
Souffle Therapeutics's latest disclosed round is Series A at $200m (Oct 07, 2025).
Who invested in Souffle Therapeutics?
Souffle Therapeutics has 1 institutional investors on this page, including Bessemer Venture Partners.
How does CrackTheDeck cover Souffle Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the Souffle Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.